Literature DB >> 22074644

Alterations in the emotional and memory behavioral phenotypes of transient receptor potential vanilloid type 1-deficient mice are mediated by changes in expression of 5-HT₁A, GABA(A), and NMDA receptors.

In-Jee You1, Yang-Hee Jung, Min-Jung Kim, Seung-Hwan Kwon, Sa-Ik Hong, Seok-Yong Lee, Choon-Gon Jang.   

Abstract

The transient receptor potential vanilloid type 1 channel (TRPV1) receptors are expressed in various regions of the brain. Much less is known about whether TRPV1 receptors affect higher brain functions. In the present study, we demonstrated that TRPV1-knockout (TRPV1KO) mice showed antidepressant-like behaviors in a novelty-suppressed feeding test and forced swim test when compared to wild-type (WT) mice. Additionally, TRPV1KO mice exhibited increased aggressiveness and reduced social interactions in a social dominance test and social interaction test. TRPV1KO mice showed reduced short-term memory and normal long-term memory in a novel object recognition test and passive avoidance test versus WT mice. Based on these behavioral data, we investigated changes in specific receptors related to depression, anxiety, and memory in the brains of TRPV1KO and WT mice. Binding of [(3)H]-8-OH-DPAT was significantly higher in the frontal associated cortex (FrA), nucleus accumbens (NAc), and the cingulate cortex (CC) of TRPV1KO mice than WT mice, while the expression of 5-HT(1A) receptors was higher in the FrA, NAc, and cortex of TRPV1KO mice than WT mice. [(3)H]-flunitrazepam binding was also significantly higher in the FrA, striatum (CPU), and the CC of TRPV1KO versus WT mice. In contrast, [(3)H]-musicmol binding in the FrA, CPU, NAc, CC, and the dentate gyrus (DG) was significantly lower in TRPV1KO mice than WT mice. The expression of GABA(A)γ(2) was higher in the NAc, CPU, and cortex of TRPV1KO versus WT mice, whereas the expression of GABA(A)α(2) was lower in the FrA, CPU, NAc, and cortex in TRPV1KO mice than WT mice. Finally, [(3)H]-MK-801 binding was decreased in the CPU and CA1 of TRPV1KO versus WT mice. The expression of NR2A was lower in the hippocampus of TRPV1KO versus WT mice. These data suggest that the loss of TRPV1 results in antidepressant-like, anxiolytic, abnormal social and reduced memorial behaviors due to changes in expression of 5-HT(1A), GABA(A,) and NMDA receptors. This article is part of a Special Issue entitled 'Post-Traumatic Stress Disorder'.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22074644     DOI: 10.1016/j.neuropharm.2011.10.013

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  19 in total

1.  Depressive behavior in the forced swim test can be induced by TRPV1 receptor activity and is dependent on NMDA receptors.

Authors:  Ramy E Abdelhamid; Katalin J Kovács; Myra G Nunez; Alice A Larson
Journal:  Pharmacol Res       Date:  2013-11-04       Impact factor: 7.658

2.  Effects of intranasal administration of the peptide antagonist of type I vaniloid receptor (TRPV1) in the rodent central nervous system.

Authors:  A O Tishkina; E K Mart'yanova; Yu A Logashina; Ya A Andreev; S F Khaibullina; E V Martynova; A A Rizvanov; N V Gulyaeva; E V Grishin
Journal:  Dokl Biol Sci       Date:  2016-11-08

3.  The blockade of transient receptor potential ankirin 1 (TRPA1) signalling mediates antidepressant- and anxiolytic-like actions in mice.

Authors:  Juliana Cavalcante de Moura; Maíra Macedo Noroes; Vanessa de Paula Soares Rachetti; Bruno Lobão Soares; Delia Preti; Romina Nassini; Serena Materazzi; Ilaria Maddalena Marone; Daiana Minocci; Pierangelo Geppetti; Elaine Cristina Gavioli; Eunice André
Journal:  Br J Pharmacol       Date:  2014-09       Impact factor: 8.739

4.  Chronic adolescent exposure to ∆9-tetrahydrocannabinol decreases NMDA current and extrasynaptic plasmalemmal density of NMDA GluN1 subunits in the prelimbic cortex of adult male mice.

Authors:  Virginia M Pickel; Faye Bourie; June Chan; Ken Mackie; Diane A Lane; Gang Wang
Journal:  Neuropsychopharmacology       Date:  2019-07-19       Impact factor: 7.853

5.  Involvement of 2-arachidonoylglycerol signaling in social challenge responding of male CD1 mice.

Authors:  Mano Aliczki; Zoltan Kristof Varga; Zoltan Balogh; Jozsef Haller
Journal:  Psychopharmacology (Berl)       Date:  2014-12-31       Impact factor: 4.530

6.  Loss of interneuron LTD and attenuated pyramidal cell LTP in Trpv1 and Trpv3 KO mice.

Authors:  Travis E Brown; Anda M Chirila; Benjamin R Schrank; Julie A Kauer
Journal:  Hippocampus       Date:  2013-06-03       Impact factor: 3.899

7.  Effects of glutamate NMDA and TRPV1 receptor antagonists on the biphasic responses to anandamide injected into the dorsolateral periaqueductal grey of Wistar rats.

Authors:  Manoela V Fogaça; Felipe V Gomes; Fabrício A Moreira; Francisco S Guimarães; Daniele C Aguiar
Journal:  Psychopharmacology (Berl)       Date:  2012-11-27       Impact factor: 4.530

8.  Sociability development in mice with cell-specific deletion of the NMDA receptor NR1 subunit gene.

Authors:  Sarah L Ferri; Ashley A Pallathra; Hyong Kim; Holly C Dow; Praachi Raje; Mary McMullen; Warren B Bilker; Steven J Siegel; Ted Abel; Edward S Brodkin
Journal:  Genes Brain Behav       Date:  2019-12-12       Impact factor: 3.449

9.  Multiple Forms of Endocannabinoid and Endovanilloid Signaling Regulate the Tonic Control of GABA Release.

Authors:  Sang-Hun Lee; Marco Ledri; Blanka Tóth; Ivan Marchionni; Christopher M Henstridge; Barna Dudok; Kata Kenesei; László Barna; Szilárd I Szabó; Tibor Renkecz; Michelle Oberoi; Masahiko Watanabe; Charles L Limoli; George Horvai; Ivan Soltesz; István Katona
Journal:  J Neurosci       Date:  2015-07-08       Impact factor: 6.167

10.  Experimental Malaria in Pregnancy Induces Neurocognitive Injury in Uninfected Offspring via a C5a-C5a Receptor Dependent Pathway.

Authors:  Chloë R McDonald; Lindsay S Cahill; Keith T Ho; Jimmy Yang; Hani Kim; Karlee L Silver; Peter A Ward; Howard T Mount; W Conrad Liles; John G Sled; Kevin C Kain
Journal:  PLoS Pathog       Date:  2015-09-24       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.